Gilead makes key hiring amid M&A rumours.
Moving EMA could slow approval process, warns Guido Rasi
Novartis, J&J, Verily and Philips will all feature at this year’s Digital Health Summit.
Massachusetts-based company will test the waters for biotech sector
Biogen’s SMA treatment approved – but price is $125,000 per dose
Alliance will seek to improve screening for common diabetic vision conditions.